<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="123921">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01489293</url>
  </required_header>
  <id_info>
    <org_study_id>MMC110053CTIL</org_study_id>
    <nct_id>NCT01489293</nct_id>
  </id_info>
  <brief_title>Inhibitory Receptors in Eosinophils of Atopic Subjects</brief_title>
  <official_title>Characterization of the Expression and Activity of Inhibitory Receptors Such as CLM-1 in Eosinophils of Atopic Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to analyze the expression and activity of inhibitory molecules
      on eosinophils obtained from allergic subjects.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>Expression of surface molecules on eosinophils as assessed by flow cytometry</measure>
    <time_frame>December 2013</time_frame>
    <description>Blood samples from donors will be stained and evaluated by flow cytomtery</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Atopy</condition>
  <condition>Atopic Dermatitis</condition>
  <condition>Asthma</condition>
  <condition>Allergic Rhinitis</condition>
  <condition>Food Allergy</condition>
  <arm_group>
    <arm_group_label>atopic subjects</arm_group_label>
    <description>Patients with one atopic disease or more (atopic dermatitis,rhinitis, asthma, food allergy)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-atopic subjects</arm_group_label>
    <description>Control group without atopic diseases.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        allergy clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 20-60 years

          -  a physician-diagnosed atopic disease

        Exclusion Criteria:

          -  atopic disease not active

          -  steroid treatment

          -  active non-atopic inflammatory disease, including infections

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alon Y Hershko, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Meir Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alon Y Hershko, MD PhD</last_name>
    <phone>972-50-207-6448</phone>
    <email>alon.hershko@clalit.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Meir Medical Center. Unit of Allergy and Clinical Immunology</name>
      <address>
        <city>Kfar Saba</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Alon Y Hershko, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <lastchanged_date>March 3, 2013</lastchanged_date>
  <firstreceived_date>December 7, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Rhinitis, Allergic</mesh_term>
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Atopic</mesh_term>
    <mesh_term>Eczema</mesh_term>
    <mesh_term>Food Hypersensitivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
